NLRP3-IN-20

NLRP3-IN-20 is a potent and orally bioavailable NLRP3 inflammasome inhibitor, demonstrating an IC50 of 25 nM against IL-1β release. It has shown significant therapeutic efficacy in preclinical models of inflammatory diseases, including non-alcoholic steatohepatitis, septic shock, and colitis.